Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 12
2022 10
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Shankar-Hari M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, Savovic J, Tierney J, Baron G, Benbenishty JS, Berry LR, Broman N, Cavalcanti AB, Colman R, De Buyser SL, Derde LPG, Domingo P, Omar SF, Fernandez-Cruz A, Feuth T, Garcia F, Garcia-Vicuna R, Gonzalez-Alvaro I, Gordon AC, Haynes R, Hermine O, Horby PW, Horick NK, Kumar K, Lambrecht BN, Landray MJ, Leal L, Lederer DJ, Lorenzi E, Mariette X, Merchante N, Misnan NA, Mohan SV, Nivens MC, Oksi J, Perez-Molina JA, Pizov R, Porcher R, Postma S, Rajasuriar R, Ramanan AV, Ravaud P, Reid PD, Rutgers A, Sancho-Lopez A, Seto TB, Sivapalasingam S, Soin AS, Staplin N, Stone JH, Strohbehn GW, Sunden-Cullberg J, Torre-Cisneros J, Tsai LW, van Hoogstraten H, van Meerten T, Veiga VC, Westerweel PE, Murthy S, Diaz JV, Marshall JC, Sterne JAC. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, et al. JAMA. 2021 Aug 10;326(6):499-518. doi: 10.1001/jama.2021.11330. JAMA. 2021. PMID: 34228774 Free PMC article.
NAT2 phenotype alters pharmacokinetics of rivaroxaban in healthy volunteers.
Villapalos-García G, Zubiaur P, Ochoa D, Soria-Chacartegui P, Navares-Gómez M, Matas M, Mejía-Abril G, Casajús-Rey A, Campodónico D, Román M, Martín-Vílchez S, Candau-Ramos C, Aldama-Martín M, Abad-Santos F. Villapalos-García G, et al. Among authors: mejia abril g. Biomed Pharmacother. 2023 Sep;165:115058. doi: 10.1016/j.biopha.2023.115058. Epub 2023 Jun 28. Biomed Pharmacother. 2023. PMID: 37385211 Free article.
Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide.
Soria-Chacartegui P, Zubiaur P, Ochoa D, Navares-Gómez M, Abbes H, Villapalos-García G, de Miguel A, González-Iglesias E, Rodríguez-Lopez A, Mejía-Abril G, Martín-Vilchez S, Luquero-Bueno S, Román M, Abad-Santos F. Soria-Chacartegui P, et al. Among authors: mejia abril g. Int J Mol Sci. 2023 Oct 17;24(20):15265. doi: 10.3390/ijms242015265. Int J Mol Sci. 2023. PMID: 37894954 Free PMC article.
CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride.
Campodónico DM, Zubiaur P, Soria-Chacartegui P, Casajús A, Villapalos-García G, Navares-Gómez M, Gómez-Fernández A, Parra-Garcés R, Mejía-Abril G, Román M, Martín-Vílchez S, Ochoa D, Abad-Santos F. Campodónico DM, et al. Among authors: mejia abril g. Clin Transl Sci. 2022 Nov;15(11):2613-2624. doi: 10.1111/cts.13386. Epub 2022 Sep 6. Clin Transl Sci. 2022. PMID: 36065758 Free PMC article. Clinical Trial.
Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics.
Zubiaur P, Fernández-Campos P, Navares-Gómez M, Soria-Chacartegui P, Villapalos-García G, Román M, Mejía-Abril G, Ochoa D, Abad-Santos F. Zubiaur P, et al. Among authors: mejia abril g. Pharmaceutics. 2021 Sep 28;13(10):1573. doi: 10.3390/pharmaceutics13101573. Pharmaceutics. 2021. PMID: 34683865 Free PMC article.
Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam.
Zubiaur P, Figueiredo-Tor L, Villapalos-García G, Soria-Chacartegui P, Navares-Gómez M, Novalbos J, Matas M, Calleja S, Mejía-Abril G, Román M, Ochoa D, Abad-Santos F. Zubiaur P, et al. Among authors: mejia abril g. Biomed Pharmacother. 2022 Nov;155:113747. doi: 10.1016/j.biopha.2022.113747. Epub 2022 Sep 24. Biomed Pharmacother. 2022. PMID: 36162369 Free article.
32 results